<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260128068685N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-06</date_registration>
      <primary_sponsor>University of Isfahan</primary_sponsor>
      <public_title>The effect of dynamic neuromuscular stability (DNS) exercises with and without abdominal maneuver (ADIM)</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Eight-Week Dynamic Neuromuscular Stabilization (DNS) Training With and Without Abdominal Drawing-In Maneuver (ADIM) on Balance, Pulmonary Function Indices, Motor Performance, and Quality of Life in Individuals with Incomplete Paraplegic Spinal Cord Injury</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/88811</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Participants were assigned to two intervention groups (DNS with ADIM and DNS without ADIM) using a paired random allocation method based on the ASIA scale using Randomizer.org software. This method maintains balance between groups and reduces selection bias.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Incomplete Paraplegic Spinal Cord Injury.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants will perform dynamic neuromuscular stability exercises with abdominal drawing-in maneuvers under the supervision of a therapist for 8 weeks, 3 sessions per week, 45 minutes each session. The exercise program includes modified core stability patterns in seated functional positions appropriate to the ability of individuals with spinal cord injury, and the intensity and progression of the exercises will gradually increase over the course. All sessions will be performed with the same protocol and under the supervision of the researcher. Intervention 2: Control group: Participants will receive the same dynamic neuromuscular stability exercises with the same order, duration, intensity, and number of sessions for 8 weeks, 3 sessions per week, each session lasting 45 minutes, except that the abdominal drawing-in maneuver is not performed during the exercises. All sessions will be supervised by the researcher and will follow the same protocol.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Hossein Jafari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Isfahan, Gharazi Street, Kheradmand Street, Baharan Alley 1 West_Plate 24</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>08196353191</zip>
        <telephone>+98 31 3457 2317</telephone>
        <email>mh.jafari@spr.ui.ac.ir</email>
        <affiliation>The University of Isfahan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Gholamali Ghasemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Sport Sciences, University of Isfahan, Azadi Square, Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۸۱۷۴۶۷۳۴۴۱</zip>
        <telephone>+98 31 3793 2128</telephone>
        <email>gh.ghasemi@spr.ui.ac.ir</email>
        <affiliation>University of Isfahan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of SCI (paraplegia-incomplete) by a specialist doctor
Voluntary consent to participate in the research
Absence of other neurological diseases such as MS and ...
Ability to perform ADIM and DNS exercises (modified)
Ability to sit independently
Minimum 20 years and maximum 45 years</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Absence of more than 3 consecutive sessions or 5 alternate sessions
Pain or any problem that makes the subject's presence in the study impossible
Voluntary withdrawal from the study
History of spinal surgery or hip fracture
Chest deformity and respiratory problems
Failure to complete the tests
Minimum 20 years and maximum 45 years</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S34</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Injury of lumbar and sacral spinal cord and nerves at abdomen, lower back and pelvis level</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants will perform dynamic neuromuscular stability exercises with abdominal drawing-in maneuvers under the supervision of a therapist for 8 weeks, 3 sessions per week, 45 minutes each session. The exercise program includes modified core stability patterns in seated functional positions appropriate to the ability of individuals with spinal cord injury, and the intensity and progression of the exercises will gradually increase over the course. All sessions will be performed with the same protocol and under the supervision of the researcher.</i_keyword>
      <i_keyword>Control group: Participants will receive the same dynamic neuromuscular stability exercises with the same order, duration, intensity, and number of sessions for 8 weeks, 3 sessions per week, each session lasting 45 minutes, except that the abdominal drawing-in maneuver is not performed during the exercises. All sessions will be supervised by the researcher and will follow the same protocol.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Maximum functional reach distance in the Modified Functional Reach Test (MFRT) in centimeters, measured before the start of the intervention and immediately after the end of the 8-week intervention. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Modified Functional Reach Test.</prim_outcome>
      <prim_outcome>Forced expiratory volume in one second (FEV1) measured by digital spirometry in liters, before the start of the intervention and immediately after the end of the 8-week intervention. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Digital spirometer device.</prim_outcome>
      <prim_outcome>Forced vital capacity (FVC) measured by digital spirometry in liters, before the start of the intervention and immediately after the end of the 8-week intervention. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Digital spirometer device.</prim_outcome>
      <prim_outcome>Core trunk muscle endurance based on the duration of maintaining the position in the modified Planck test, in seconds, measured before the start of the intervention and immediately after the end of the 8-week intervention. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Modified Plank test.</prim_outcome>
      <prim_outcome>قدرت عضلات فلکسور تنه اندازه‌گیری‌شده با دینامومتر، بر حسب نیوتن، پیش از شروع مداخله و بلافاصله پس از پایان مداخله ۸ هفته‌ای. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Dynamometer device.</prim_outcome>
      <prim_outcome>Trunk extensor muscle strength measured with a dynamometer, in Newtons, before the start of the intervention and immediately after the end of the 8-week intervention. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Dynamometer device.</prim_outcome>
      <prim_outcome>Intra-abdominal pressure measured with a manometer, in centimeters of water (cmH₂O), before the start of the intervention and immediately after the end of the 8-week intervention. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Manometer (intra-abdominal pressure gauge).</prim_outcome>
      <prim_outcome>The kyphosis angle of the back region measured with a kyphometer, in degrees, before the start of the intervention and immediately after the end of the 8-week intervention. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Kyphometer device.</prim_outcome>
      <prim_outcome>Quality of Life Index (QLI) score, measured before the start of the intervention and immediately after the end of the 8-week intervention. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Quality of Life Index.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life index score, measured before the start of the intervention and immediately after the end of the 8-week intervention. Timepoint: Measurements were taken at two time points, including before the start of the intervention (pre-test) and immediately after the end of the 8-week intervention period (post-test). Method of measurement: Quality of Life Index.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Isfahan</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-02-21</approval_date>
        <contact_name>Ethics Committee of the University of Isfahan</contact_name>
        <contact_address>No. 24, West Baharan Alley 1, Kheradmand Street, Gharazi Street, Isfahan Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
